Boditech Med Inc. (KOSDAQ:206640)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,530
+120 (0.89%)
At close: Dec 5, 2025
-18.20%
Market Cap 294.73B
Revenue (ttm) 151.75B
Net Income (ttm) 27.23B
Shares Out 21.78M
EPS (ttm) 1,250.08
PE Ratio 10.82
Forward PE n/a
Dividend 150.00 (1.11%)
Ex-Dividend Date Mar 31, 2025
Volume 19,631
Average Volume 45,870
Open 13,460
Previous Close 13,410
Day's Range 13,270 - 13,550
52-Week Range 12,940 - 18,670
Beta 0.23
RSI 48.18
Earnings Date Nov 12, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Sector Healthcare
Founded 1998
Employees 541
Stock Exchange KOSDAQ
Ticker Symbol 206640
Full Company Profile

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.

Financial Statements

News

There is no news available yet.